The Barrier Disruption and Pyroptosis of Intestinal Epithelial Cells Caused by Perfringolysin O (PFO) from Clostridium perfringens
Author:
Liu Zhankui1234, Mou Shuang1234, Li Liang1234, Chen Qichao1234, Yang Ruicheng1234ORCID, Guo Shibang1234, Jin Yancheng1234, Liu Lixinjie1234, Li Tianzhi1234, Chen Huanchun1234, Wang Xiangru1234ORCID
Affiliation:
1. National Key Laboratory of Agricultural Microbiology, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan 430070, China 2. Key Laboratory of Preventive Veterinary Medicine in Hubei Province, The Cooperative Innovation Center for Sustainable Pig Production, Wuhan 430070, China 3. Engineering Research Center of Animal Biopharmaceuticals, The Ministry of Education of the People’s Republic of China (MOE), Wuhan 430070, China 4. Frontiers Science Center for Animal Breeding and Sustainable Production, Wuhan 430070, China
Abstract
Clostridium perfringens (C. perfringens), a Gram-positive bacterium, produces a variety of toxins and extracellular enzymes that can lead to disease in both humans and animals. Common symptoms include abdominal swelling, diarrhea, and intestinal inflammation. Severe cases can result in complications like intestinal hemorrhage, edema, and even death. The primary toxins contributing to morbidity in C. perfringens-infected intestines are CPA, CPB, CPB2, CPE, and PFO. Amongst these, CPB, CPB2, and CPE are implicated in apoptosis development, while CPA is associated with cell death, increased intracellular ROS levels, and the release of the inflammatory factor IL-18. However, the exact mechanism by which PFO toxins exert their effects in the infected gut is still unidentified. This study demonstrates that a C. perfringens PFO toxin infection disrupts the intestinal epithelial barrier function through in vitro and in vivo models. This study emphasizes the notable influence of PFO toxins on intestinal barrier integrity in the context of C. perfringens infections. It reveals that PFO toxins increase ROS production by causing mitochondrial damage, triggering pyroptosis in IPEC-J2 cells, and consequently resulting in compromised intestinal barrier function. These results offer a scientific foundation for developing preventive and therapeutic approaches against C. perfringens infections.
Funder
National Key Research and Development Program of China National Natural Science Foundation of China Natural Science Foundation of Hubei Province Fundamental Research Funds for the Central Universities China Agriculture Research System of MOF and MARA
Reference50 articles.
1. Towards an understanding of the role of Clostridium perfringens toxins in human and animal disease;Uzal;Future Microbiol.,2014 2. Huang, S., Tian, Y., Wang, Y., García, P., Liu, B., Lu, R., Wu, L., Bao, H., Pang, M., and Zhou, Y. (2022). The Broad Host Range Phage vB_CpeS_BG3P Is Able to Inhibit Clostridium perfringens Growth. Viruses, 14. 3. Foodborne Disease Outbreaks in Correctional Institutions-United States, 1998–2014;Marlow;Am. J. Public Health,2017 4. Camargo, A., Guerrero-Araya, E., Castañeda, S., Vega, L., Cardenas-Alvarez, M.X., Rodríguez, C., Paredes-Sabja, D., Ramírez, J.D., and Muñoz, M. (2022). Intra-species diversity of Clostridium perfringens: A diverse genetic repertoire reveals its pathogenic potential. Front. Microbiol., 13. 5. Effect of oat hulls as a free choice feeding on broiler performance, short chain fatty acids and microflora under a mild necrotic enteritis challenge;Kheravii;Anim. Nutr.,2018
|
|